Home/ Supplements/ Niacin/ Nibiru Pineapple Strawberry

Nibiru Pineapple Strawberry

product on market Powder Eclipse Safety: 97/100
97/100

This product looks safe

  • Vitamin B3: 50mg is 1.4× the Tolerable Upper Intake Level (35mg)
  • 46% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains L-Citrulline and Beta-Alanine, which have strong evidence for improving exercise performance and endurance. Vitamin B3, L-Carnitine-L-Tartrate, and Taurine provide moderate support for energy metabolism and cellular function. The ingredient profile is supported by established research with a high safety score.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Vitamin B3: 50mg is 1.4× the Tolerable Upper Intake Level (35mg)

Label

Product Label

Label for Nibiru Pineapple Strawberry
Open Full PDF View on NIH DSLD →
Details

Label Data

6300 mg
Serving Size
42
Servings
Other Combinations
Product Type
46%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

50 mg (250% DV)
Exceeds UL by 1.4× (UL: 35 mg) 196 studies (A:5, B:63)
1600 mg
Market median: 1500.0mg (104 products) 21 studies (A:0, B:2)
1500 mg
Market median: 2000.0mg (275 products)
Market median: 500.0mg (861 products) 61 studies (A:4, B:13)
500 mg
Market median: 500.0mg (180 products) 5 studies (A:0, B:1)
Market median: 180.0mg (239 products) 49 studies (A:1, B:19)
CholinAce
150 mg
Black Walnut (Juglans regia) extract
50 mg
GBBgo
50 mg
Rauwolscine
1 mg
Yohimbine
1 mg

Other Ingredients

Maltodextrin Citric Acid Sucralose Natural flavors Acesulfame Potassium Calcium Silicate
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

As a dietary supplement, take one to two scoops before strenuous exercise. Each one-scoop serving is to be dissolved into 6-8 ounces of water. Do not exceed 2 scoops in a 24-hour period.

Formulation Notes

Increased stamina Accelerated fat loss Concentrated energy

Additional Information

Description Nibiru the destroyer. This pre-workout is designed to take your performance to another level! Nibiru is an energy matrix that stimulates mental focus to increase strength & power! Let Nibiru be your pre-workout of choice when the going gets tough.

Pre workout

Metadata

Product Details

UPC / SKU7 66234 85475 7
DSLD Entry Date2021-07-27
Product TypeOther Combinations
FormPowder
BrandEclipse
DSLD ID252022
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.